Serum Uric Acid

Angiology - Tập 63 Số 6 - Trang 420-428 - 2012
Zhengyun Zhang1,2, Lu‐Qin Bian3, Yoon‐Ho Choi4
1Department of Surgery, Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiaotong University, Shanghai, China
2Transplantation Research Center, Samsung Biomedical Research Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
3Department of Pneumoconiosis, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China
4Center for Health Promotion, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea

Tóm tắt

Serum uric acid (SUA) is a potential risk factor for atherosclerosis. We assessed the relationship between SUA and subclinical atherosclerosis in Korean men (n = 3010). Multidetector computed tomography (MDCT) and ultrasonographic measurements of coronary artery calcification (CAC) and carotid intima–media thickness (cIMT), respectively, are markers of subclinical atherosclerosis. Odds ratios (ORs) of CAC score and cIMT across SUA levels were 1.101 ( P = .046) and 1.266 ( P = .002), respectively, after adjustment for several variables. The independent association between CAC and cIMT was observed (OR = 1.231, P < .001). Serum uric acid was independently associated with metabolic syndrome (MetS) with an OR of 1.415 ( P < .001). Metabolic syndrome was only independently associated with cIMT, with an OR of 2.103 ( P = .003). High-sensitivity C-reactive protein was positively correlated with SUA ( r = .125, P < .001). Serum uric acid level is independently associated with CAC, cIMT, and MetS in Korean men.

Từ khóa


Tài liệu tham khảo

10.7326/0003-4819-131-1-199907060-00003

10.1016/j.metabol.2006.05.013

10.1111/j.1742-1241.2005.00621.x

10.1016/j.amjhyper.2006.06.015

10.1161/01.HYP.35.3.746

10.1161/01.CIR.0000017502.58595.ED

10.1093/oxfordjournals.eurheartj.a015352

Mustard JF, 1963, Can Med Assoc J, 89, 1207

10.1177/0961203309355301

10.1291/hypres.27.227

10.2337/diacare.26.4.1251

10.1093/oxfordjournals.aje.a009302

10.1161/hc4601.099486

10.4065/74.3.243

10.1161/CIRCULATIONAHA.106.178458

National Kidney Foundation, 2002, Am J Kidney Dis, 39, S1, 10.1016/S0272-6386(02)70081-4

10.1016/S1071-3581(03)00653-6

10.1016/j.ahj.2007.02.035

10.1097/00132577-200512000-00018

10.1001/archinte.164.12.1285

10.1016/j.archger.2010.05.020

10.1016/S0002-9149(01)01548-X

10.1161/01.CIR.97.23.2302

10.1291/hypres.28.27

10.1111/j.1523-1755.2004.00973.x

10.1016/S0735-1097(01)01781-8

10.1056/NEJM199807233390404

10.1161/01.CIR.102.9.1014

10.1056/NEJM199505043321804

10.1016/B978-0-7216-0284-4.50020-8

10.1161/01.ATV.0000161274.87407.26

10.1016/j.atherosclerosis.2004.12.016

10.1016/j.atherosclerosis.2010.11.034

Mancini GB, 2004, Circulation, 109, IV22

10.1161/01.CIR.99.20.2633

10.1067/mhj.2003.6

10.1016/j.amjcard.2007.02.046

10.1001/jama.297.11.1197

Przewłocki T, 2009, Kardiol Pol, 67, 978

10.1016/S0140-6736(05)67702-1

10.1056/NEJMoa032804

10.1161/01.CIR.0000097109.90783.FC

10.1016/j.atherosclerosis.2009.08.037

10.1016/j.atherosclerosis.2011.01.040

10.1016/j.atherosclerosis.2008.04.045

10.1172/JCI40124